Full Press Release Details
International to Present at Stifel Nicolaus 2012 Healthcare Conference
Mont. August 31, 2012 - Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone
graft material and antimicrobial coatings for medical applications, will present at the Stifel Nicolaus 2012 Healthcare
Conference. The conference will be held at the Four Seasons Hotel in Boston, Massachusetts on September 5-6, 2012. Bacterin is
scheduled to present on Thursday, September 6, 2012 at 9:45 a.m. Eastern time, with one-on-one meetings held throughout the day.
Management will discuss the company's business plan and objectives
for the remainder of 2012. The presentation will be available via webcast at: http://www.veracast.com/webcasts/stifel/healthcare2012/55204615.cfm.
For more information about the conference or to schedule a one-on-one
meeting with Bacterin management, contact your Stifel representative.
About Bacterin International
Bacterin International
Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's
proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral
repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief
of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral
repair in knee and other joint surgeries.
Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic
coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further
information, please visit www.bacterin.com.
Regarding Forward-looking Statements
This news release contains
certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive
in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts,"
"expects," "anticipates," "intends," "plans," "believes," "estimates,"
"projects," "forecasts," "strategy," "will," "goal," "target," "prospects,"
"potential," "optimistic," "confident," "likely," "probable" or similar expressions
or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these
statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of
important factors, including, among others: the Company's ability to launch beta and full product releases, the Company's ability
to obtain FDA concurrence use for anti-microbial coatings in a timely manner; the Company's ability to meet its obligations under
existing and anticipated contractual obligations; the Company's ability to develop, market, sell and distribute desirable applications,
products and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results;
the ability of the Company's customers to pay and the timeliness of such payments, particularly during recessionary periods; the
Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to
attract and retain management and employees with appropriate skills and expertise; the impact of increased taxation, changes in
market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other
factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K under the heading "Risk Factors."
The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
James Carbonara, Regional
Brett Maas, Managing